Jonathan Silverberg, MD, PhD, MPH (@JonathanMd) profile picture

Dr. Silverberg is a Professor of Dermatology at the George Washington University School of Medicine and Health Sciences

Joined January 2019
Photo by Jonathan Silverberg, MD, PhD, MPH (@JonathanMd)Photo by Jonathan Silverberg, MD, PhD, MPH (@JonathanMd)Photo by Jonathan Silverberg, MD, PhD, MPH (@JonathanMd)Photo by Jonathan Silverberg, MD, PhD, MPH (@JonathanMd)Photo by Jonathan Silverberg, MD, PhD, MPH (@JonathanMd)Photo by Jonathan Silverberg, MD, PhD, MPH (@JonathanMd)Photo by Jonathan Silverberg, MD, PhD, MPH (@JonathanMd)Photo by Jonathan Silverberg, MD, PhD, MPH (@JonathanMd)Photo by Jonathan Silverberg, MD, PhD, MPH (@JonathanMd)Photo by Jonathan Silverberg, MD, PhD, MPH (@JonathanMd)
Jonathan Silverberg, MD, PhD, MPH retweeted
You’re invited to the December virtual update on Revolutionizing Atopic Dermatitis! Get ready for CME/CE with practical patient-centered conversations and presentations on late-breaking research. Join us on December 8: bit.ly/3Z1YMaW @JonathanMd , @RajMDPhD
1
1
133
Jonathan Silverberg, MD, PhD, MPH retweeted
31) There is growing evidence that JAK inhibitors are efficacious in #atopic_dermatitis, #alopecia_areata, #psoriasis, & #vitiligo. Additional evidence suggests that JAK inhibition may be broadly useful in dermatology, with early reports of efficacy in several other conditions.
1
1
2
Jonathan Silverberg, MD, PhD, MPH retweeted
29) Studies in Japanese adults with #AD of #topical #delgocitinib 0.5% ointment have been promising. See 🔓jaad.org/article/S0190-9622(…
1
1
2
Jonathan Silverberg, MD, PhD, MPH retweeted
25b) Significant itch reductions versus vehicle were reported within 12 hours of first application of 1.5% RUX (P < .05). Application site reactions were infrequent (<1%) and lower with RUX versus vehicle; none were clinically significant.
1
1
1
Jonathan Silverberg, MD, PhD, MPH retweeted
24a) Indeed, there are 2⃣: Topical #Ruxolitinib Evaluation in #Atopic_Dermatitis Study 1 (NCT03745638) & Study 2 (NCT03745651) #TRuE_AD enrolled patients aged ≥12 yrs with AD for ≥2 yrs, an Investigator's Global Assessment score of 2/3, and 3%-20% affected body surface area.
1
1
1
Jonathan Silverberg, MD, PhD, MPH retweeted
10a) Thus #JAK inhibition can block the effects of multiple cytokines that are major players in #AD pathophysiology & ⬇️symptomatology. As per previous expert tweetorials from @DrStevenTChen @itchdoctor @Aller_MD (still available for CE/#CME credit at academiccme.com/dermatology-…)...
1
1
2
Jonathan Silverberg, MD, PhD, MPH retweeted
9) The #JAK-#STAT signaling pathway mediates effects of several key #cytokines on immune cells, keratinocytes, and peripheral sensory neurons that lead to inflammation and itch, including IL-4, IL-5, IL-13, IL31, IL-22, and TSLP See pubmed.ncbi.nlm.nih.gov/3443….
1
1
2
Jonathan Silverberg, MD, PhD, MPH retweeted
4) Of late there is substantial interest in #topical #Janus_kinase (#JAK) inhibitors for treatment of #AD. New topical JAK inhibitors include #ruxolitinib (which blocks JAK1/2) and delgocitinib (pan-JAK inhibitor).
1
1
2
Jonathan Silverberg, MD, PhD, MPH retweeted
3) Atopic dermatitis (#AD) is a chronic inflammatory skin disease with heterogenous presentation and often a heavy patient-burden & ⬇️#qualityoflife. Targeted treatment options that are effective & safe are currently limited.
1
1
2
Jonathan Silverberg, MD, PhD, MPH retweeted
Don't miss the 4th Annual RAD Conference, April 9-11, at the Renaissance Baltimore Harborplace Hotel. View the full agenda: revolutionizingad.com/confer… Register: https://teapaw.org/t.co/FbDCqxzBVR 50% DISCOUNT CODE: RAD22SM50IP in-person and RAD22SM50V for virtual #atopicdermatitis #CME
2
1
Jonathan Silverberg, MD, PhD, MPH retweeted
Only a few days left to submit Late Breaker Abstracts for the Revolutionizing Atopic Dermatitis Conference being held at the Renaissance Baltimore Harborplace Hotel April 9-11, 2022. Learn more and submit your abstract here: revolutionizingad.com/confer… #atopicdermatitis #dermatology
2
3
Jonathan Silverberg, MD, PhD, MPH retweeted
Join us at the Renaissance Baltimore Harborplace Hotel for the 4th Annual Revolutionizing Atopic Dermatitis Conference in April. Today is the last day for early bird pricing. Register now: revolutionizingad.com/confer… #RAD2022 #atopicdermatitis #dermatology #allergist #physicians
Jonathan Silverberg, MD, PhD, MPH retweeted
Virtual Conference is coming December 11-13, 2021. Are you ready? Visit revolutionizingad.com/ to ✅ all of these things off your list! #RAD2021 #atopicdermatitis #dermatology #immunology #allergy #physicians #nurses #Pharmaceutical
1
2
Jonathan Silverberg, MD, PhD, MPH retweeted
Join us at our 1st mini-symposium at our Dec 11-13 Virtual Conference. Our panelists includes (left to right): Raj Chovatiya, MD, PhD; Jonathan I. Silverberg, MD, PhD, MPH; Anne Marie Singh, MD; Jacob P. Thyssen, Professor, MD, PhD, DmSci. Register now: revolutionizingad.com/
1
1
Jonathan Silverberg, MD, PhD, MPH retweeted
View the abstract submission guidelines and submit your abstract for the upcoming Revolutionizing Atopic Dermatitis Conference: https://teapaw.org/t.co/vZCuC77G9i #atopicdermatitis #dermatology #immunology #allergy #sleepmedicine #physicians #nurses @nationaleczema @eczemaresearch
4
7
Jonathan Silverberg, MD, PhD, MPH retweeted
Findings that were presented at Revolutionizing Atopic Dermatitis 2021 were recently published in @MDedgeDerm . Read the full article here: https://teapaw.org/t.co/6A7xTDg6AG #dermatology #dermatologists #atopicdermatitis #dermtwitter #physicians
2
2
Jonathan Silverberg, MD, PhD, MPH retweeted
What does the future hold for Atopic Dermatitis treatment? Over the next few months, 5 new treatments are expected to be approved and commercially available for the treatment of atopic dermatitis. To learn more, join us at RAD: revolutionizingad.com/ #atopicdermatitis
2
2
Jonathan Silverberg, MD, PhD, MPH retweeted
To learn more about #AtopicDermatitis, join us at RAD on June 13. We will review the latest developments in state-of-the art therapies and prepare you for the next generation of AD treatments! Early bird registration rates available through May 15: revolutionizingad.com/
Jonathan Silverberg, MD, PhD, MPH retweeted
A multidisciplinary team-based approach is necessary to optimize treatment for #atopicdermatitis. Join us virtually on 6/13 at the RAD Conference to learn how dermatologists can work alongside other medical disciplines to achieve the best outcomes. More: https://teapaw.org/t.co/acdSEAAZPA
2
1